Current Gene Therapy


Liang Cheng
College of Bioinformatics Science and Technology
Harbin Medical University
Harbin, Heilongjiang

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:17   Issue: 4
Pp: 259-260
Michele Simonato
DOI: 10.2174/156652321704180104153220

Editorial: CRISPR Medicine: From Bench to Bedside free to download

Volume:17   Issue: 4
Pp: 261-262
Graham Dellaire
DOI: 10.2174/156652321704180104153508

CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo

Volume:17   Issue: 4
Pp: 263-274
Jayme Salsman, Jean-Yves Masson, Alexandre Orthwein* and Graham Dellaire*
DOI: 10.2174/1566523217666171122094629

CRISPR/Cas9 Editing to Facilitate and Expand Drug Discovery

Volume:17   Issue: 4
Pp: 275-285
Francis Robert, Sidong Huang and Jerry Pelletier*
DOI: 10.2174/1566523217666171121164615

New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish

Volume:17   Issue: 4
Pp: 286-300
Sergey V. Prykhozhij , Lucia Caceres and Jason N. Berman
DOI: 10.2174/1566523217666171121164132

Therapeutic Applications of CRISPR/Cas for Duchenne Muscular Dystrophy

Volume:17   Issue: 4
Pp: 301-308
Tatianna Wai Ying Wong and Ronald D. Cohn*
DOI: 10.2174/1566523217666171121165046

First-in-human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready? open access plus

Volume:17   Issue: 4
Pp: 309-319
Francoise Baylis* and Marcus McLeod
DOI: 10.2174/1566523217666171121165935

The Progress of Gene Therapy for Leber's Optic Hereditary Neuropathy open access plus

Volume:17   Issue: 4
Pp: 320-326
Yong Zhang, Zhen Tian, Jiajia Yuan, Chang Liu, Hong li Liu, Si Qi Ma and Bin Li*
DOI: 10.2174/1566523218666171129204926